Found: 2
Select item for more details and to access through your institution.
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 11, p. 3053, doi. 10.1002/ijc.32882
- By:
- Publication type:
- Article
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 2963, doi. 10.1002/ijc.32316
- By:
- Publication type:
- Article